305 related articles for article (PubMed ID: 17165435)
41. Gestational trophoblastic disease.
Soper JT
Obstet Gynecol; 2006 Jul; 108(1):176-87. PubMed ID: 16816073
[TBL] [Abstract][Full Text] [Related]
42. Influence of hydatidiform mole follow-up setting on postmolar gestational trophoblastic neoplasia outcomes: a cohort study.
Dantas PR; Maestá I; Cortés-Charry R; Growdon WB; Braga A; Rudge MV; Berkowitz RS
J Reprod Med; 2012; 57(7-8):305-9. PubMed ID: 22838246
[TBL] [Abstract][Full Text] [Related]
43. Molar pregnancy in adolescents.
Braga A; Growdon WB; Bernstein M; Maestá I; Rudge MV; Goldstein DP; Berkowitz RS
J Reprod Med; 2012; 57(5-6):225-30. PubMed ID: 22696817
[TBL] [Abstract][Full Text] [Related]
44. A clinico-pathological study of complete and partial hydatidiform moles in a Nigerian population.
Osamor JO; Oluwasola AO; Adewole IF
J Obstet Gynaecol; 2002 Jul; 22(4):423-5. PubMed ID: 12521470
[TBL] [Abstract][Full Text] [Related]
45. Epidemiological report on the treatment of patients with gestational trophoblastic disease in 10 Brazilian referral centers: results after 12 years since International FIGO 2000 Consensus.
Braga A; Uberti EM; Fajardo Mdo C; Viggiano M; Sun SY; Grillo BM; Padilha SL; de Andrade JM; de Souza CB; Madi JM; Maestá I; Silveira E
J Reprod Med; 2014; 59(5-6):241-7. PubMed ID: 24937964
[TBL] [Abstract][Full Text] [Related]
46. [Clinical analysis of 13 cases of gestational trophoblastic tumor misdiagnosed as ectopic pregnancy].
Qian JH; Ye DF; Xie X
Zhonghua Fu Chan Ke Za Zhi; 2005 Feb; 40(2):91-4. PubMed ID: 15840286
[TBL] [Abstract][Full Text] [Related]
47. Subsequent pregnancy outcomes in patients with molar pregnancy and persistent gestational trophoblastic neoplasia.
Garrett LA; Garner EI; Feltmate CM; Goldstein DP; Berkowitz RS
J Reprod Med; 2008 Jul; 53(7):481-6. PubMed ID: 18720922
[TBL] [Abstract][Full Text] [Related]
48. Duration of human chorionic gonadotropin surveillance for partial hydatidiform moles.
Lavie I; Rao GG; Castrillon DH; Miller DS; Schorge JO
Am J Obstet Gynecol; 2005 May; 192(5):1362-4. PubMed ID: 15902109
[TBL] [Abstract][Full Text] [Related]
49. Prognosis of malignant gestational trophoblastic neoplasia: 20 years of experience.
Yang JJ; Xiang Y; Wan XR; Yang XY
J Reprod Med; 2008 Aug; 53(8):600-7. PubMed ID: 18773625
[TBL] [Abstract][Full Text] [Related]
50. Risk of gestational trophoblastic neoplasia after hCG normalisation according to hydatidiform mole type.
Schmitt C; Doret M; Massardier J; Hajri T; Schott AM; Raudrant D; Golfier F
Gynecol Oncol; 2013 Jul; 130(1):86-9. PubMed ID: 23523617
[TBL] [Abstract][Full Text] [Related]
51. Live birth following treatment of post molar choriocarcinoma.
Gurung G; Ojha N; Amatya A; Shrestha I; Kc N; Poudel S; Rana A
Nepal Med Coll J; 2009 Mar; 11(1):66-8. PubMed ID: 19769244
[TBL] [Abstract][Full Text] [Related]
52. Management of gestational trophoblastic neoplasia with 5-fluorouracil and actinomycin D in northern China.
Zhao Y; Zhang W; Duan W
J Reprod Med; 2009 Feb; 54(2):88-94. PubMed ID: 19301571
[TBL] [Abstract][Full Text] [Related]
53. Management of postmolar gestational trophoblastic disease with methotrexate and folinic acid: 15 years of experience.
Sekharan PK; Sreedevi NS; Radhadevi VP; Beegam R; Raghavan J; Guhan B
J Reprod Med; 2006 Oct; 51(10):835-40. PubMed ID: 17086813
[TBL] [Abstract][Full Text] [Related]
54. Gestational trophoblastic disease in Tunisia.
Mourali M; Fkih C; Essoussi-Chikhaoui J; Ben Haj Hassine A; Binous N; Ben Zineb N; Boussen H
Tunis Med; 2008 Jul; 86(7):665-9. PubMed ID: 19472728
[TBL] [Abstract][Full Text] [Related]
55. Clinicopathologic characteristics and subsequent pregnancy outcome in 139 complete hydatidiform moles.
Horn LC; Kowalzik J; Bilek K; Richter CE; Einenkel J
Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):10-4. PubMed ID: 16530318
[TBL] [Abstract][Full Text] [Related]
56. [Survey of gestational trophoblastic disease incidence among 3.6 million pregnancies in China].
Shi YF; Li JQ; Zheng W; Chen XJ; Qiao YH; Hao M; Zhou CW; Hu YL; Wan GM; Sha YC; Zheng X
Zhonghua Fu Chan Ke Za Zhi; 2005 Feb; 40(2):76-8. PubMed ID: 15840282
[TBL] [Abstract][Full Text] [Related]
57. Management of gestational trophoblastic neoplasia.
Horowitz NS; Goldstein DP; Berkowitz RS
Semin Oncol; 2009 Apr; 36(2):181-9. PubMed ID: 19332252
[TBL] [Abstract][Full Text] [Related]
58. Indoleamine 2,3-dioxygenase expression in gestational trophoblastic disease: implications for development of immunotherapeutic approaches.
Sebire NJ; Fisher RA; Williams S; Prendergast G; Savage P; Seckl M
J Reprod Med; 2008 Oct; 53(10):789-92. PubMed ID: 19004406
[TBL] [Abstract][Full Text] [Related]
59. [Trophoblastic diseases].
ten Kate-Booij MJ; Lok CA; Verheijen RH; Massuger LF; van Trommel NE
Ned Tijdschr Geneeskd; 2008 Oct; 152(41):2219-24. PubMed ID: 19009808
[TBL] [Abstract][Full Text] [Related]
60. Expression of maspin in gestational trophoblastic disease.
Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
